NASDAQ:HTWR (HTWR) (HTWR) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free HTWR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$57.98▼$57.9850-Day Range N/A52-Week Range$25.01▼$87.38VolumeN/AAverage Volume528,597 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (HTWR) alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. About (HTWR) Stock (NASDAQ:HTWR)Heartware International, Inc. is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices. The HeartWare Ventricular Assist System (HVAD System), which includes a ventricular assist device (VAD) or blood pump, patient accessories and surgical tools, provides circulatory support for patients in the advanced stage of heart failure. The HVAD System is designed to be implanted adjacent to the heart, avoiding abdominal surgery. The HVAD System features the centrifugal pump designed to be implanted in the chest, directly adjacent to the heart. It develops MVAD System, a miniaturized device. The CircuLite Surgical System is designed to be implanted through a right, mini-thoracotomy procedure and does not require a sternotomy or cardiopulmonary bypass.Read More Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. HTWR Stock News HeadlinesMarch 13, 2024 | msn.comCandace Owens is betting her entire career on a baseless conspiracy about Macron's wifeFebruary 7, 2024 | msn.comWinged Bean: What Nutritionists Say About Its Health Effects And MoreApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. February 7, 2024 | msn.comMadhya Pradesh: Official Suspended For Neglecting Board Exam Duty In NarmadapuramFebruary 7, 2024 | msn.comCity of Albuquerque settles lawsuit over rape kit backlogOctober 9, 2023 | msn.comHow to Get the Lululemon Look for an Affordable Price Right on AmazonOctober 9, 2023 | msn.comDesigner Bags, That Are Way More AffordableMarch 30, 2023 | msn.comPepsi overhauls logo and visual identity after 14 yearsApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. March 30, 2023 | msn.comLogan McGinn gearing up for this weekend’s Drive Chip & Putt finals at Augusta NationalJanuary 24, 2023 | msn.comIndian industry turns to biomass as capital bans coal in pollution fightJanuary 13, 2023 | msn.comLocal law makers say there are ‘no simple answers’ ahead of sessionNovember 29, 2022 | msn.comElle-Máijá Tailfeathers on challenge of portraying an Indigenous cop on 'Three Pines'October 7, 2022 | msn.comI lost because foreign powers, multinationals meddled in election, Raila now saysSeptember 6, 2022 | thestreet.comHeartWare (HTWR) Stock Skyrocketing on Medtronic DealAugust 30, 2022 | msn.comSadiq Khan: Next PM must ditch “anti-London agenda” and work with City HallAugust 4, 2022 | msn.comSF Giants find new ways to leave bases loaded in seventh straight loss to DodgersSee More Headlines Receive HTWR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (HTWR) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/28/2016Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:HTWR CUSIP42236810 CIK1389072 Webwww.heartware.com Phone+1-508-7390873FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report HTWR Stock Analysis - Frequently Asked Questions How were (HTWR)'s earnings last quarter? (HTWR) (NASDAQ:HTWR) announced its quarterly earnings results on Thursday, July, 28th. The medical instruments supplier reported ($0.43) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.82) by $0.39. The medical instruments supplier earned $68.72 million during the quarter, compared to the consensus estimate of $57.36 million. The business's revenue for the quarter was down 6.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.47) EPS. What other stocks do shareholders of (HTWR) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (HTWR) investors own include Nuwellis (CHFS), Netflix (NFLX), (MDVN) (MDVN), AllianceBernstein (AB), Align Technology (ALGN), Arctos NorthStar Acquisition (ANAC), American Express (AXP), Electronic Arts (EA), Express Scripts (esrx) and Gilead Sciences (GILD). This page (NASDAQ:HTWR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (HTWR) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
